Quais são as probabilidades atuais de Will FDA approve any mRNA vaccine against glioblastoma before 2028??

A Manifold Markets cota No em 80.1% em 26 de outubro de 2026.

Negociar em simulação

Will FDA approve any mRNA vaccine against glioblastoma before 2028?

Saúde e medicinaOne-Off1a

Manifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibrado

Aviso de qualidade dos dadosDados da fonte degradados

Dados de 26 de out. de 2026, 05:51 UTC · política pm-quality-4

Previsão da comunidade atual

Não 80.1%

Previsores

Tipo de pergunta

binary

Metodologia

Play-money forecasting platform

Tipo de fonte

Previsão

Dados do mercado

Atualizado há 5 horas

Desatualizado

21/02/23, 20:21 UTC31/12/27, 22:59 UTC

Tendências

Resultado24hProbabilidade

Regras

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of glioblastoma in the United States before January 1, 2028.

This does not include emergency use authorization or other forms of limited authorization.
Resolves NO otherwise.

Reportar um problema de dados deste mercado

Will FDA approve any mRNA vaccine against glioblastoma before 2028?

Will FDA approve any mRNA vaccine against glioblastoma before 2028?

Mercados abertos

Hantavirus pandemic in 2026?

Will the FDA approve any psychedelic substance for medical use this year?

How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

Will a pneumonic plague case be reported in the U.S. this year?

Pandemic in 2026?

Measles cases in U.S. in 2026?

Perguntas frequentes

Use este mercado em código ou em um agente de IA

Mercados abertos

Hantavirus pandemic in 2026?

Will the FDA approve any psychedelic substance for medical use this year?

How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?

Will a pneumonic plague case be reported in the U.S. this year?

Pandemic in 2026?

Measles cases in U.S. in 2026?